Mahul B. Amin, MD is an internationally recognized researcher, leading urologic pathologist and highly effective operations executive, with consistent success heading up clinical practice and research transformations in translational pathology, leading growth, and increasing industry recognition for large laboratories. In his most recent position as Medical Director, Chairman and Professor of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center, he transformed the community-based practice into internationally recognized academic department. Previously, as Director of Surgical Pathology at Emory University Hospital, he led the strategic and operational reorganization of the entire Surgical Pathology services with focus on quality, turnaround time and service accountability, and planned and oversaw reconstruction of the facilities. Beginning on January 1, 2017, Dr Amin will be the Gerwin Endowed Chair for Cancer Research and Professor and Chairman of the Department of Pathology and Lab Medicine at University of Tennessee Health Sciences Center.
Dr. Amin earned his medical degree at G.S. Medical College and King Edward Memorial Hospital in Bombay, India. He is a national and international consultant in tumors of the genitourinary tract, including prostate, urinary bladder, kidney, and testis. From 2001 to 2009, as Vice Chair and then as Chair of the Cancer Committee of the College of American Pathologists (CAP), Dr. Amin has led the cause for standardized pathologic reporting of all cancer in the United States and the committees’ work resulted in one of the important standards of the American College of Surgeons, Commission on Cancer center accreditation program in the United States and the CAP’s laboratory accreditation program. In 2013, he was appointed as Editor-in-Chief of the 8th edition of the American Joint Committee on Cancer (AJCC) staging manual where he has coordinated the activities of over 425 contributors from 184 institutions, 23 countries, and 5 continents to outline the latest edition of the cancer staging manual, available October 2016.